Total Payments
$1,110
2024 Payments
$115.99
Companies
15
Transactions
22
Medicare Patients
1,208
Medicare Billing
$113,884
Payment Breakdown by Category
Food & Beverage$618.81 (55.8%)
Consulting$491.00 (44.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $618.81 | 21 | 55.8% |
| Consulting Fee | $491.00 | 1 | 44.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $491.00 | 1 | $0 (2020) |
| Inari Medical, Inc. | $167.00 | 1 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $115.99 | 1 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $90.43 | 5 | $0 (2019) |
| GlaxoSmithKline, LLC. | $62.64 | 2 | $0 (2023) |
| Allergan Inc. | $32.97 | 2 | $0 (2019) |
| Synergy Pharmaceuticals Inc | $27.42 | 2 | $0 (2018) |
| Merck Sharp & Dohme LLC | $21.17 | 1 | $0 (2023) |
| Medtronic, Inc. | $19.34 | 1 | $0 (2022) |
| Melinta Therapeutics, Inc. | $16.13 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $115.99 | 1 | Janssen Scientific Affairs, LLC ($115.99) |
| 2023 | $266.89 | 5 | Inari Medical, Inc. ($167.00) |
| 2022 | $19.34 | 1 | Medtronic, Inc. ($19.34) |
| 2020 | $491.00 | 1 | Stryker Corporation ($491.00) |
| 2019 | $65.35 | 4 | Allergan Inc. ($18.40) |
| 2018 | $138.37 | 9 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($72.86) |
| 2017 | $12.87 | 1 | Daiichi Sankyo Inc. ($12.87) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/25/2024 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Food and Beverage | In-kind items and services | $115.99 | General |
| Category: Immunology | ||||||
| 12/28/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $31.66 | General |
| Category: RESPIRATORY | ||||||
| 06/14/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $30.98 | General |
| Category: RESPIRATORY | ||||||
| 06/14/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/24/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $167.00 | General |
| Category: VTE | ||||||
| 03/21/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.08 | General |
| 10/18/2022 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Gastrointestinal AI | ||||||
| 10/31/2020 | Stryker Corporation | NEW PRODUCT DEVELOPMENT (Device) | Consulting Fee | Cash or cash equivalent | $491.00 | General |
| Category: NEW PRODUCT DEVELOPMENT | ||||||
| 06/10/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/29/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Immunology | ||||||
| 02/28/2019 | Melinta Therapeutics, Inc. | Vabomere (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: ANTIBIOTICS | ||||||
| 02/14/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/18/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Gastroenterology | ||||||
| 08/14/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/07/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/18/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXANIBSD (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/22/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Gastroenterology | ||||||
| 05/15/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXANIBSD (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/03/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: NEPHROLOGY | ||||||
| 03/05/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), XIFAXAN, RELISTOR ORAL | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/30/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), RELISTOR | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/02/2017 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 412 | 489 | $177,941 | $35,291 |
| 2022 | 14 | 397 | 502 | $145,435 | $41,349 |
| 2021 | 3 | 99 | 143 | $30,539 | $12,202 |
| 2020 | 11 | 300 | 358 | $112,389 | $25,041 |
Total Patients
1,208
Total Services
1,492
Medicare Billing
$113,884
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 32 | 32 | $32,933 | $5,633 | 17.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 45 | 46 | $11,040 | $4,452 | 40.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 45 | 71 | $10,173 | $4,178 | 41.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 46 | 47 | $42,457 | $3,696 | 8.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 39 | 41 | $19,821 | $3,133 | 15.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 45 | 79 | $6,322 | $2,850 | 45.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 46 | $8,280 | $2,738 | 33.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $7,744 | $2,308 | 29.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 28 | 29 | $20,940 | $1,907 | 9.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $7,786 | $1,461 | 18.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 13 | 13 | $4,680 | $1,186 | 25.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 27 | $3,105 | $1,015 | 32.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 14 | 14 | $2,660 | $735.72 | 27.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 37 | 76 | $13,908 | $5,808 | 41.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 29 | 30 | $21,150 | $5,502 | 26.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 78 | $9,906 | $4,142 | 41.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 55 | $9,900 | $3,521 | 35.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 43 | 45 | $26,685 | $3,158 | 11.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 32 | 32 | $7,680 | $3,123 | 40.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 19 | $6,764 | $2,840 | 42.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 31 | 31 | $9,455 | $2,606 | 27.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 34 | 34 | $11,526 | $2,385 | 20.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 32 | 32 | $7,744 | $2,173 | 28.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $7,560 | $1,993 | 26.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $6,972 | $1,849 | 26.5% |
About Dr. Syed Hassan, MD
Dr. Syed Hassan, MD is a Gastroenterology healthcare provider based in Lafayette, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/17/2014. The National Provider Identifier (NPI) number assigned to this provider is 1689098311.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Syed Hassan, MD has received a total of $1,110 in payments from pharmaceutical and medical device companies, with $115.99 received in 2024. These payments were reported across 22 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($618.81).
As a Medicare-enrolled provider, Hassan has provided services to 1,208 Medicare beneficiaries, totaling 1,492 services with total Medicare billing of $113,884. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology, Internal Medicine
- Location Lafayette, IN
- Active Since 02/17/2014
- Last Updated 01/14/2026
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1689098311
Products in Payments
- NEW PRODUCT DEVELOPMENT (Device) $491.00
- FLOWTRIEVER CATHETER, S (Device) $167.00
- STELARA (Biological) $115.99
- AREXVY (Drug) $62.64
- XIFAXAN (Drug) $38.54
- XIFAXANIBSD (Drug) $35.99
- Trulance (Drug) $27.42
- DIFICID (Drug) $21.17
- GI GENIUS (Device) $19.34
- TEFLARO (Drug) $18.40
- Vabomere (Drug) $16.13
- RELISTOR (Drug) $15.90
- AVYCAZ (Drug) $14.57
- Humira (Biological) $13.25
- INJECTAFER (Drug) $12.87
- SAMSCA (Drug) $11.82
- ELIQUIS (Drug) $11.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lafayette
Dr. Kerri Glassner, D.o, D.O
Gastroenterology — Payments: $75,707
Gastroenterology $75,707
Dr. Jacob Karr, Md, MD
Gastroenterology — Payments: $42,466
Gastroenterology $42,466
Mr. Jacque Noel, Md, MD
Gastroenterology — Payments: $11,841
Gastroenterology $11,841
Dr. Ramu Raju, Md, MD
Gastroenterology — Payments: $11,609
Gastroenterology $11,609
Dr. Stephen Abshire, Md, MD
Gastroenterology — Payments: $8,695
Gastroenterology $8,695
Jacob Breaux, M.d, M.D
Gastroenterology — Payments: $8,611
Gastroenterology $8,611